|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBOOKCENTRAL_ocn952773667 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
110811s2012 nyu ob 001 0 eng |
010 |
|
|
|a 2020686441
|
040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d XFH
|d VLY
|d UMMBL
|d OCLCF
|d OCLCO
|d OCLCA
|d OCLCO
|d OCLCQ
|d E7B
|d YDXCP
|d EBLCP
|d LOA
|d MERUC
|d PIFPO
|d ZCU
|d STF
|d WRM
|d NRAMU
|d ICG
|d VT2
|d DKC
|d UKCRE
|d QGK
|d OCLCO
|d OCLCL
|
019 |
|
|
|a 849920834
|a 961667961
|a 962576381
|a 1153507947
|a 1259082997
|
020 |
|
|
|a 9781621004912
|q (ebook)
|
020 |
|
|
|a 1621004910
|
020 |
|
|
|z 9781621004318
|q (hardcover)
|
020 |
|
|
|a 1621004317
|
020 |
|
|
|a 9781621004318
|
029 |
1 |
|
|a AU@
|b 000053305977
|
029 |
1 |
|
|a DEBBG
|b BV044089475
|
029 |
1 |
|
|a NZ1
|b 15493020
|
035 |
|
|
|a (OCoLC)952773667
|z (OCoLC)849920834
|z (OCoLC)961667961
|z (OCoLC)962576381
|z (OCoLC)1153507947
|z (OCoLC)1259082997
|
042 |
|
|
|a pcc
|
050 |
0 |
0 |
|a RM666.H28
|
060 |
|
4 |
|a QV 193
|
082 |
0 |
0 |
|a 615.7/18
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Heparin :
|b properties, uses, and side effects /
|c David E. Piyathilake and Rhong Liang, editors.
|
264 |
|
1 |
|a New York :
|b Nova Science Publishers, Inc.,
|c [2012]
|
300 |
|
|
|a 1 online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Pharmacology - Research, Safety Testing and Regulation Biochemistry Research Trends
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a The pharmacology of oral heparins -- Suppression of membrane vesiculation : a possible anticoagulant, Antimetastatic and anti-inflammatory effect of heparin -- Beyond anticoagulation : roles for heparin in the vasculature -- Heparin monitoring : from blood tube to microfluidic device -- Advances in the analysis of the heparins -- Searching for heparin binding partners -- Heparin-related nanomaterials -- Pharmacokinetic differences among unfractionated heparin and low molecular weight heparins : impact in patients with renal impairment -- Comprehensive and updated study on the analysis techniques of heparin for human use -- The elaboration of new blood plasma anticoagulant complexes of high-molecular-weight heparin with glyproline peptides main amino acids on the base of mathematical simulation of pH- metry data -- Application of chemometric techniques to heparin purity analysis and quality control using proton NMR spectral data -- Heparin : the side effect of heparin, particularly, heparin induced thrombocytopenia.
|
588 |
|
|
|a Description based on print version record and CIP data provided by publisher.
|
546 |
|
|
|a English.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Heparin.
|
650 |
|
0 |
|a Anticoagulants (Medicine)
|
650 |
1 |
2 |
|a Heparin
|
650 |
|
2 |
|a Anticoagulants
|
650 |
|
6 |
|a Héparine.
|
650 |
|
6 |
|a Anticoagulants.
|
650 |
|
7 |
|a Anticoagulants (Medicine)
|2 fast
|
650 |
|
7 |
|a Heparin
|2 fast
|
655 |
|
4 |
|a Libros electronicos.
|
700 |
1 |
|
|a Piyathilake, David E.,
|e editor.
|
700 |
1 |
|
|a Liang, Rhong,
|e editor.
|
758 |
|
|
|i has work:
|a Heparin (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCYB9kTgmq7GMBRBjxKhMWC
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|t Heparin
|d New York : Nova Science Publishers, Inc., [2012]
|z 9781621004318 (hardcover)
|w (DLC) 2011034014
|
830 |
|
0 |
|a Pharmacology - Research, Safety Testing and Regulation Biochemistry Research Trends.
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3022365
|z Texto completo
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3022365
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10704556
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 7078305
|
994 |
|
|
|a 92
|b IZTAP
|